Superworth

Matinas BioPharma EPS MTNB

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$18.15
Latest quarter, Q2 FY26
−$3.15
Fiscal year 2025
−$30.90

Matinas BioPharma's earnings per share was −$18.15 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$3.15.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$30.90n/a
FY2024−$75.00n/a
FY2023−$84.15n/a
FY2022n/an/a
FY2021−$82.50n/a
FY2020−$90.00n/a
FY2019−$105.00n/a
FY2018−$120.00n/a
FY2017−$277.50n/a
FY2016−$157.50n/a
FY2015−$142.50n/a
FY2014−$240.00n/a
FY2013−$150.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$3.15n/a−$18.15
Q1 FY26−$4.50n/a−$30.45
Q4 FY25−$4.50n/a−$30.90
Q3 FY25−$6.00n/a−$51.30
Q2 FY25−$15.45n/a−$58.05
Q1 FY25−$4.95n/a−$59.85
Q4 FY24−$24.90n/a−$75.00
Q3 FY24−$12.75n/a−$68.40
Q2 FY24−$17.25n/a−$76.50
Q1 FY24−$20.10n/a−$81.75
Q4 FY23−$18.30n/a−$84.15
Q3 FY23−$20.85n/a−$80.85

Against its peers

Companies in Healthcare nearest Matinas BioPharma's size, closest first, today.

CompanyEPS, 12 monthsGrowth
MTNBMatinas BioPharma−$18.15
OXBROXBRIDGE RE HOLDINGS$0.02
EDUCEducational Development$0.19
GTIMGood Times Restaurants$0.21+75% a year
MDRRMedalist Diversified$3.84
Peer median$0.20

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Matinas BioPharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.